NetworkNewsBreaks

ThursdayJun 30, 2022 1:09 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation in Upcoming Webinar Focused on Revolutionizing Development of Plant-Based Food Products

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide food and beverage, biotherapeutics, and personal wellness industries, will e participating in a June 30 webinar sponsored by FORCE Family Office. Titled “Revolutionizing the Development of Plant-Based Food Products,” the real-time, interactive event will provide information about PBIO’s three pressure-based technology platforms, with an emphasis on the company’s Ultra Shear Technology(TM) (“UST”) platform. The company is inviting investors, analysis and advisors to attend the presentation, which will include a question-and-answer segment. The webinar is scheduled…

Continue Reading

ThursdayJun 30, 2022 1:02 pm

NetworkNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) KWC Launches Ketamine Wellness Integrative Therapist Directory

Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), today officially launched the Ketamine Wellness Integrative Therapist Directory. According to the update, the comprehensive resource will connect KWC patients with qualified mental health practitioners who can help them process and integrate the benefits of ketamine therapy into their everyday life. “Ketamine therapy is a rapidly growing medical field demonstrating promising results, but many patients overlook the importance of continuous cognitive therapy after their ketamine treatments to maximize the outcomes,” said Kevin Nicholson, CEO of KWC…

Continue Reading

ThursdayJun 30, 2022 12:50 pm

NetworkNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTC: LQWDF) Expands Coverage Routes by Adding 17 New Routing Nodes

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a company focused on building infrastructure on the Bitcoin Lightning Network global micropayment system, has launched 17 new international routing nodes on Lighting Network. The company’s international routing nodes now include Japan, England, Canada, US-West, France, Italy, Indonesia, Bahrain, South Africa, South Korea, Sweden, Singapore, Brazil, Germany, India, Ireland and Hong Kong. According to the announcement, these new nodes put LQwD in a position to secure future routing fees in the growing global payments network. The company noted that it is seeing consistent upward trends, a 138% increase in total network capacity since last year at this same time. With other enterprises and exchanges such as Kraken, Robinhood,…

Continue Reading

WednesdayJun 29, 2022 2:46 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Focused on International Strategy to Reach ‘Larger Consumer Base’

Flora Growth Corp. (NASDAQ: FLGC) CEO Luis Merchan is quoted in a recent article saying, “International growth is a key objective of our company’s strategy.” Earlier this year, the company completed the acquisition of 100% equity interests of Just Brands LLC and High Roller Private Label LLC, owners of the JustCBD brand, in a move by Flora Growth to explore global expansion opportunities and increase its customer database. The article reads: “By mid-May 2022, Flora Growth had already announced the expansion of its operational footprint in Europe and the United Kingdom to further its international growth strategy… In what marks…

Continue Reading

WednesdayJun 29, 2022 2:22 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Stand Distinct, Push Brand

Lexaria Bioscience Corp. (NASDAQ: LEXX) acknowledges consumers’ shift away from smoking cigarettes to nicotine alternatives, which has resulted in the growth of the nicotine pouch and nicotine replacement therapy (“NRT”) markets. Through its patented DehydraTECH technology, Lexaria looks to tap into the multibillion-dollar nicotine alternatives industry and stamp its position. “In a move that sought to prove DehydraTECH’s superiority, Lexaria conducted an oral nicotine absorption study in 2021. The research showed that Lexaria’s DehydraTECH-nicotine delivered via an oral pouch product dispensed enough nicotine levels in blood plasma in four minutes, as concentration-matched controls did in 45 minutes. In addition, peak…

Continue Reading

WednesdayJun 29, 2022 2:10 pm

NetworkNewsBreaks – Industrial Nanotech Inc. (INTK) Announces Update Regarding Supply Chain Issue

Industrial Nanotech (OTC: INTK), a global nanoscience solutions and research leader, today announced resolution of a major recent supply chain issue. “One of our top selling products for major industrial customers is EPX-H2O. This is what companies like Exxon and Nestle and industries like the railroad industry and chemical manufacturing use,” said Stuart Burchill, CEO of Industrial Nanotech. “Very recently we were informed that a key resin used in EPX-H2O was not available in inventory and would no longer be manufactured and we had to halt production. This impacted Q2 2022 revenue and, as required, we promptly informed our shareholders…

Continue Reading

WednesdayJun 29, 2022 1:55 pm

NetworkNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Scaling Capacity on Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”), has been scaling its capacity on the LN to drive awareness and growth. “The company’s flagship platform-as-a-service (‘PaaS’) offering, https://lqwd.tech/, was released in November 2021 in addition to the first company node on the Lightning Network – US-West. As the company’s longest operating node, the US-West node’s capacity is the highest – 5.73377252 BTC, which translates to 573,377,252 Satoshi/ US$121,051.86. Currently, 104 channels and 103 connected nodes are active on the network to the company’s Lightning Network node.…

Continue Reading

WednesdayJun 29, 2022 12:37 pm

NetworkNewsBreaks – Marathon Digital Holdings Inc. (NASDAQ: MARA) Issues Update on Montana-Based Bitcoin Mining Operations

Marathon Digital Holdings (NASDAQ: MARA), a leader in supporting and securing the bitcoin ecosystem, has disclosed that, as a result of a storm that passed through Hardin, Montana, earlier this month, the company’s mining operations in the region are currently without power and likely to remain offline until the damaged power generating facility can be repaired. Based on the latest inspection reports, Marathon’s Montana-based miners may have sufficient power to come back online in a reduced capacity as early as the first week of July. “The severe storm in Montana unexpectedly decreased our hash rate in June and presented us…

Continue Reading

WednesdayJun 29, 2022 12:11 pm

NetworkNewsBreaks – Prime Harvest Inc. Featured in Latest Episode of Bell2Bell Podcast

Prime Harvest, a technology-focused, full-service cannabis company with horizontally diversified operations spanning various segments of the cannabis value chain, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Duane Alexander, CEO of Prime Harvest, joined the latest episode to discuss to discuss the company, its flagship brand and seasoned management team, recent milestones, and goals for the balance of 2022 and beyond. “Prime Harvest is a vertically integrated cannabis company. We’re based out of San Diego … and we’re positioned to expand into other markets in the…

Continue Reading

WednesdayJun 29, 2022 11:57 am

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Completes Safety Evaluation of Cohort II for Novel Drug to Treat Concussion

Odyssey Health (OTC: ODYY), f/k/a Odyssey Group International Inc., a company focused on developing unique, life-saving medical products, today announced positive safety findings from cohort II of its phase I clinical trial. According to the update, the trial involves administering PRV-002, Odyssey’s novel drug to treat concussion, to healthy human subjects. Cohort II data indicates that the drug was safe and well-tolerated. “PRV-002 continues to be well-tolerated as we increase the intranasal dose levels,” said Michael Redmond, CEO of Odyssey Health. “We look forward to completing phase I clinical trials and moving into a phase II/III to determine the efficacy…

Continue Reading